Wellbutrin SR is a sustained‑release form of bupropion, an atypical antidepressant that modulates norepinephrine and dopamine. It is commonly prescribed for major depressive disorder and, under the brand Zyban, supports smoking cessation. The SR formulation delivers steady blood levels with twice‑daily dosing and is often chosen for its activating profile, weight‑neutral tendency, and lower risk of sexual side effects compared with many SSRIs. When used as directed, it can improve mood, energy, and concentration. Surgery Center of Pottsville offers a structured pathway to access Wellbutrin SR under clinician oversight, prioritizing safety and continuity of care from consultation through pharmacy fulfillment.
Wellbutrin SR is an atypical antidepressant approved for the treatment of major depressive disorder (MDD) in adults. By enhancing norepinephrine and dopamine signaling, it can lift mood, increase drive, and improve concentration and productivity in people whose depression presents with low energy and anhedonia. Bupropion SR is also marketed as Zyban for smoking cessation; in that context, it reduces nicotine cravings and withdrawal symptoms and may double quit rates compared with placebo when paired with behavioral support.
Clinicians sometimes choose Wellbutrin SR over serotonergic antidepressants because it is generally weight‑neutral and has a lower likelihood of sexual side effects. It tends to be activating rather than sedating, which can benefit patients with fatigue or psychomotor slowing. Note that Wellbutrin XL (extended‑release) is the bupropion product labeled for seasonal affective disorder (SAD); SR and XL differ in release profile and dosing frequency.
Dosing must be individualized by a licensed clinician. For major depressive disorder, a common initiation is 150 mg once daily in the morning for 3 days, then an increase to 150 mg twice daily if tolerated. Doses should be taken at least 8 hours apart to minimize seizure risk. The typical target dose is 300 mg per day (150 mg twice daily). Some patients may be increased cautiously, but do not exceed the maximum per current labeling. Always swallow SR tablets whole; do not crush, split, or chew, as that can rapidly release the dose and increase adverse effects.
For smoking cessation (bupropion SR/Zyban), many protocols begin with 150 mg once daily for 3 days, then 150 mg twice daily, with a planned quit date during week 2. Duration is often 7–12 weeks, with extensions when clinically appropriate. Take with or without food; if nausea occurs, taking with food may help. Insomnia is dose‑related—avoid taking near bedtime. Dose adjustments or extended dosing intervals may be required in hepatic or renal impairment and in older adults.
Never take more than prescribed or combine Wellbutrin SR with other bupropion‑containing products (e.g., Wellbutrin XL, Aplenzin, Zyban), as this increases the risk of seizures and other adverse effects.
Bupropion lowers the seizure threshold in a dose‑dependent manner. Adhering to prescribed dosing, spacing doses at least 8 hours apart, and avoiding duplicative bupropion products are key safety measures. Use caution in conditions or with medicines that further lower the seizure threshold (see Drug Interactions).
Monitor blood pressure periodically; hypertension can occur, especially when combined with nicotine replacement therapy. Screen for bipolar disorder before starting any antidepressant—bupropion can precipitate mania/hypomania in susceptible individuals. Watch for clinical worsening or suicidality, particularly in young adults during the first few months or at dose changes; involve a clinician if concerning symptoms arise.
Avoid or minimize alcohol; abrupt alcohol or benzodiazepine discontinuation increases seizure risk. Angle‑closure glaucoma may be triggered in susceptible patients. In pregnancy and lactation, weigh benefits and risks carefully with a clinician; bupropion appears in breast milk. Use extra caution in hepatic or renal impairment, head trauma history, and eating disorders (see Contraindications).
Do not use Wellbutrin SR if you have a seizure disorder or a current or prior diagnosis of bulimia or anorexia nervosa—both significantly raise seizure risk. It is also contraindicated during abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs due to withdrawal‑related seizures. Do not use within 14 days of taking a monoamine oxidase inhibitor (MAOI); serious hypertensive reactions may occur.
Avoid bupropion if you’ve had a hypersensitivity reaction to bupropion or any component of the formulation (e.g., rash, pruritus, anaphylaxis, angioedema). Patients should not take more than one bupropion‑containing product simultaneously. Severe hepatic cirrhosis warrants major dose/interval adjustments and close monitoring; discuss with a specialist before initiation.
Common side effects include dry mouth, insomnia, headache, nausea, constipation, dizziness, tremor, sweating, agitation or anxiety, tachycardia/palpitations, and weight loss or decreased appetite. Many are transient and improve with time, dose adjustments, earlier dosing, or taking with food. Because bupropion is activating, some patients report jitteriness early in therapy; this often diminishes over 1–2 weeks.
Serious but less common reactions include seizures (risk increases with higher doses and predispositions), significant hypertension, severe allergic reactions (including rash, urticaria, angioedema, and rare Stevens‑Johnson syndrome), visual changes consistent with angle‑closure glaucoma, and neuropsychiatric effects such as mood swings, irritability, or suicidality. In smoking cessation, neuropsychiatric symptoms have been reported, particularly with underlying psychiatric illness. Seek urgent care for seizure, severe rash, chest pain, fainting, hallucinations, or suicidal thoughts. Report persistent insomnia, anxiety, or blood pressure elevations to your clinician; dose timing or adjustments may help.
Bupropion should not be used with MAOIs or within 14 days of MAOI discontinuation because of the risk of hypertensive crisis. Do not combine with other bupropion‑containing medicines (Wellbutrin XL, Aplenzin, Zyban), which can lead to overdose or seizures.
Bupropion is primarily metabolized by CYP2B6. Strong CYP2B6 inhibitors (e.g., ticlopidine, clopidogrel) may increase bupropion exposure, while inducers (e.g., carbamazepine, phenytoin, phenobarbital, ritonavir, efavirenz) may reduce efficacy by lowering levels. Your clinician may adjust the dose or choose alternatives accordingly.
Importantly, bupropion is a potent CYP2D6 inhibitor. It can raise concentrations of 2D6 substrates, including certain SSRIs (paroxetine, fluoxetine), SNRIs (duloxetine), TCAs (nortriptyline, desipramine), antipsychotics (risperidone, haloperidol), beta‑blockers (metoprolol), antiarrhythmics (propafenone, flecainide), and tamoxifen (potentially reducing conversion to active metabolites). Monitor for increased effects or side effects of these drugs; dose adjustments may be needed.
Medications that lower the seizure threshold require caution: other antidepressants at high doses, antipsychotics, tramadol, theophylline, systemic corticosteroids, stimulants, quinolone antibiotics, and abrupt withdrawal from alcohol or benzodiazepines. Combining bupropion with nicotine replacement can increase blood pressure—monitor regularly. Limit alcohol, as it may potentiate neuropsychiatric effects and seizure risk.
If you miss a dose of Wellbutrin SR, take it as soon as you remember—provided it is at least 8 hours before your next scheduled dose. If it is close to your next dose, skip the missed dose. Do not double up. Maintaining adequate spacing between doses reduces the risk of seizures and side effects.
Overdose can cause agitation, hallucinations, severe nausea/vomiting, rapid heart rate, confusion, loss of consciousness, seizures, conduction abnormalities, and fever. Because sustained‑release tablets may delay peak effects, symptoms can be prolonged. If an overdose is suspected, call emergency services or Poison Control (1‑800‑222‑1222 in the U.S.) immediately. Stabilization of airway, breathing, and circulation is the priority; benzodiazepines are often used to manage seizures. There is no specific antidote; treatment is supportive, and hospital observation is typically recommended.
Store Wellbutrin SR at room temperature (68–77°F/20–25°C), protected from moisture and excessive heat. Keep tablets in the original, tightly closed container and out of reach of children and pets. Do not crush or chew SR tablets. Safely dispose of expired or unused medication according to local guidelines or pharmacy take‑back programs.
In the United States, Wellbutrin SR (bupropion sustained‑release) is a prescription‑only medication. Federal and state laws require evaluation by a licensed clinician and a valid prescription before a pharmacy can dispense it. While many people search online for ways to “buy Wellbutrin SR without prescription,” obtaining prescription medicines without a clinician’s authorization is unsafe and unlawful.
Surgery Center of Pottsville offers a legal and structured solution for people seeking streamlined access: you begin with a compliant intake and clinician review (via in‑person or telehealth, depending on your location), and—if appropriate—a licensed prescriber authorizes therapy and sends the prescription directly to a U.S. pharmacy for fulfillment. This model spares you from handling paperwork while maintaining all regulatory safeguards, including identity verification, medication reconciliation, and ongoing follow‑up.
Through this clinician‑guided pathway, you gain convenient, legitimate access to authentic Wellbutrin SR, dosing tailored to your health profile, and monitoring for efficacy, side effects, and interactions. Pricing transparency, secure shipping from licensed pharmacies, and the option for refills when clinically indicated create a safe alternative to risky, unverified sources—without bypassing U.S. prescription requirements.
Wellbutrin SR is the sustained-release form of bupropion, an antidepressant that inhibits the reuptake of norepinephrine and dopamine (NDRI). By boosting these neurotransmitters, it can improve energy, motivation, and mood without significant serotonergic effects.
It is FDA-approved for major depressive disorder. The same active ingredient (bupropion SR) is FDA-approved for smoking cessation under the brand Zyban; many clinicians use generic bupropion SR for both indications.
A common regimen is 150 mg once daily in the morning for 3 days, then 150 mg twice daily, at least 8 hours apart. The usual maximum is 200 mg twice daily (400 mg/day), and single doses should not exceed 200 mg to reduce seizure risk.
Some people notice improved energy, concentration, or sleep within 1–2 weeks, but mood and full antidepressant effects often take 4–6 weeks. For smoking cessation, start 1–2 weeks before your quit date to allow the medication to reach steady effect.
Dry mouth, insomnia, headache, nausea, tremor, sweating, constipation, and increased anxiety or jitteriness are common early on. Many effects lessen over time; taking the second dose mid-afternoon (not near bedtime) can help with insomnia.
The main rare but serious risk is seizure, which increases at higher doses or with certain risk factors. Other concerns include elevated blood pressure, mood changes (including agitation or suicidal thoughts, especially in younger people), and allergic reactions; seek urgent care for severe symptoms.
Do not use if you have a seizure disorder, a current or past diagnosis of bulimia or anorexia nervosa, or are abruptly stopping alcohol, benzodiazepines, barbiturates, or antiepileptic drugs. It is also contraindicated with MAOIs taken in the past 14 days and in people with known hypersensitivity to bupropion.
Wellbutrin SR is not an anxiolytic and can feel activating at first; some people experience increased nervousness or restlessness. It can still be useful when depression coexists with mild anxiety, but primary anxiety disorders may respond better to SSRIs/SNRIs or psychotherapy.
Bupropion SR is generally weight-neutral or associated with modest weight loss due to decreased appetite. It is less likely than many SSRIs or mirtazapine to cause weight gain.
It has a low rate of sexual side effects and may even improve SSRI-related sexual dysfunction. This profile makes it a common choice when sexual function is a priority.
Limit or avoid alcohol. Drinking can raise seizure risk and worsen mood or sleep; abruptly stopping heavy alcohol use while on bupropion also increases seizure risk.
Bupropion is a strong CYP2D6 inhibitor and can raise levels of medications like certain SSRIs, SNRIs, antipsychotics, beta-blockers, and tamoxifen (potentially reducing tamoxifen’s effectiveness). Clopidogrel/ticlopidine can increase bupropion levels; ritonavir or carbamazepine can lower them. Use caution with other drugs that lower seizure threshold (tramadol, TCAs, theophylline, stimulants, systemic steroids).
No. Crushing, splitting, or chewing defeats the sustained-release mechanism and increases seizure risk. Swallow tablets whole.
If you miss a dose and it is close to the next dose, skip the missed dose and resume your usual schedule. Do not double up; spacing doses at least 8 hours apart helps lower seizure risk.
Data in pregnancy are mixed but generally reassuring; decisions should weigh depression relapse risks against potential fetal risks in consultation with a clinician. Bupropion passes into breast milk at low levels; many infants tolerate it, but monitor for irritability or poor feeding and discuss with your pediatrician and prescriber.
Bupropion is used off-label for ADHD and SAD; evidence supports benefit in some patients. Note that Wellbutrin XL, not SR, is the formulation FDA-approved for prevention of seasonal major depressive episodes.
Check baseline blood pressure and recheck periodically, especially if you have hypertension or are using nicotine replacement. Report new headaches, chest pain, or palpitations to your clinician.
Discontinuation symptoms are usually milder than with serotonergic antidepressants, but abrupt stopping can still cause irritability, mood dips, and sleep changes. A gradual taper is recommended.
Take the first dose in the morning; if prescribed twice daily, take the second dose 8 hours later, ideally mid-afternoon. Avoid taking it near bedtime to reduce insomnia.
SR is taken twice daily; XL is once daily. XL may provide smoother blood levels and is FDA-approved for prevention of seasonal depression, while SR is commonly used for major depression and, as the same active ingredient as Zyban, smoking cessation; efficacy and side effects are otherwise similar.
SR allows twice-daily dosing with lower peak-to-trough swings and fewer side effects than IR, which often requires three daily doses. Seizure risk is lower with SR at comparable total doses due to slower absorption and lower peak concentrations.
Effectiveness for major depression is broadly similar, but the side-effect profiles differ. Wellbutrin SR is more activating, with less sexual dysfunction and weight gain; SSRIs tend to be better for generalized anxiety, panic disorder, and OCD but more likely to cause sexual side effects and weight gain.
Fluoxetine is an SSRI with a long half-life and is often calming, while bupropion SR is activating and can boost energy and motivation. Bupropion has fewer sexual side effects and less weight gain; fluoxetine may be preferable for prominent anxiety or OCD.
Both treat depression; venlafaxine (an SNRI) can also help with anxiety disorders and certain pain syndromes. Bupropion SR has less sexual dysfunction and is weight-neutral; both can raise blood pressure, so monitoring is important.
Duloxetine treats depression, generalized anxiety disorder, and neuropathic or musculoskeletal pain; it can be helpful if pain is a major feature. Bupropion SR is better for low energy and has a more favorable sexual and weight profile but may be less helpful for chronic pain.
Mirtazapine commonly increases appetite, weight, and sleep—useful when insomnia and poor appetite are issues. Bupropion SR is activating and more likely to suppress appetite, with fewer sexual side effects.
Trazodone is sedating at low doses and often used off-label for insomnia rather than as a primary antidepressant. Bupropion SR is not a sleep aid and can cause insomnia, but it is generally more effective for improving energy and daytime functioning.
Vortioxetine is serotonergic with data suggesting cognitive benefits in depression and tends to have a low rate of sexual dysfunction relative to SSRIs. Bupropion SR remains strong for energy, motivation, and sexual side effects; cost and insurance coverage may favor generic bupropion.
Vilazodone is an SSRI/5-HT1A partial agonist with a relatively low sexual side-effect burden but frequent gastrointestinal upset early on. Bupropion SR avoids serotonergic GI effects and sexual dysfunction but may worsen anxiety initially.
TCAs can be very effective but have anticholinergic effects, cardiac conduction risks, and are more dangerous in overdose. Bupropion SR generally has a more favorable safety profile, though both can lower seizure threshold.
MAOIs can be highly effective for atypical or treatment-resistant depression but require strict dietary restrictions and careful drug interaction management. Bupropion SR is easier to use; never combine the two—allow proper washout (at least 14 days) to avoid serious reactions.
They contain the same active ingredient (bupropion SR) and are dosed similarly for quitting smoking: typically 150 mg daily for 3 days, then 150 mg twice daily starting 1–2 weeks before the quit date. Brand name, labeling, and insurance coverage differ; cardiovascular monitoring is advised, especially if combined with nicotine replacement.